Literature DB >> 2842887

Effect of platelet activating factor on leukocyte-endothelial cell interactions.

J G Garcia1, A Azghani, K S Callahan, A R Johnson.   

Abstract

The proinflammatory effects of platelet activating factor (PAF) that impact upon tissue inflammation were studied in vitro using the adherence of human neutrophils to endothelium and the increase in macromolecule permeability of endothelial monolayers. PAF produced both a time- and dose-dependent increase in neutrophil-endothelial cell adhesion. The adhesion promoting properties observed were primarily due to an effect of PAF on endothelium and not on neutrophils and was independent of endothelial cell cyclooxygenase products. The PAF receptor antagonist kadsurenone inhibited the adhesion response suggesting endothelial surface PAF receptors are involved in these responses. Whereas PAF alone did not alter endothelial cell barrier properties, leukocyte activation (neutrophil and platelets) with PAF produced significant increases in 125I-albumin clearance across endothelial monolayers. These studies suggest that PAF has potent proinflammatory effects and that it can play a significant role in the endothelial response to injury.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842887     DOI: 10.1016/0049-3848(88)90285-x

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Recombinant tumour necrosis factor-alpha and platelet-activating factor synergistically increase intercellular adhesion molecule-1 and E-selectin-dependent neutrophil adherence to endothelium in vitro.

Authors:  A Sterner-Kock; R K Braun; M D Schrenzel; D M Hyde
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

2.  Mechanisms of endothelial cell-dependent leukocyte adhesion stimulated by platelet-activating factor.

Authors:  Z Ding; S Li; Z Wu
Journal:  Inflammation       Date:  1992-04       Impact factor: 4.092

3.  The role of neutrophil activation in pathogenesis of preeclampsia.

Authors:  H Chen; Z Wang; M Lin
Journal:  J Tongji Med Univ       Date:  2000

4.  ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro.

Authors:  R P Brownlie; N J Brownrigg; H M Butcher; R Garcia; R Jessup; V J Lee; S Tunstall; M G Wayne
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

5.  Platelet activating factor amplifies human neutrophil adherence to bovine endothelial cells: evidence for a lipoxygenase dependent mechanism.

Authors:  B Damtew; P J Spagnuolo
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.